← Eichor
Study identifier: NCT02447861 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral Phenotypes

Condition: Microdeletion 3q29 Syndrome · Microduplication 3q29 Syndrome  ·  Sponsor: Rutgers, The State University of New Jersey

PhaseN/A
Planned participants800
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

The 3q29 deletion syndrome is caused by a deletion of a small part of human chromosome 3, and the duplication syndrome is caused by a duplication of this same small region. The purpose of this study is to understand the medical and behavioral consequences of these syndromes.

This description comes directly from the study's public registry record.

Talk to the study team

Jennifer G Mulle, MHS, PhD  ·  (848) 445-9866  ·  jennifer.mulle@rutgers.edu

Teresa Irving  ·  tmi21@cabm.rutgers.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Internet-BasedPiscataway, New Jersey, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02447861